Literature DB >> 12028087

Total thyroidectomy is now the preferred option for the surgical management of Graves' disease.

Michael S Barakate1, Gaurav Agarwal, Tom S Reeve, Bruce Barraclough, Bruce Robinson, Leigh W Delbridge.   

Abstract

PURPOSE: Subtotal thyroidectomy has been advocated as the standard treatment for Graves' disease because of the possibility of avoiding thyroxine therapy as well as the assumed lower risk of complications compared to total thyroidectomy. However, the long-term results of subtotal thyroidectomy are not as good as they were previously believed to be, as evidenced by the increasing incidence of hypothyroidism. If the risk of complications from total thyroidectomy is no higher,then that procedure offers significant advantages in the surgical management of Graves' disease. The aim of this study therefore was to compare the complication rate of the two procedures in patients with Graves' disease.
METHODS: This was a retrospective case control study in a tertiary referral hospital. Information was obtained from an endocrine surgery database over the study period from January 1957 to December 2000. During that period 1246 patients with Graves' disease underwent subtotal thyroidectomy and 119 patients underwent total thyroidectomy.
RESULTS: Prior to 1987 total thyroidectomy was rarely if ever performed whereas in the last 12 months total thyroidectomy comprised 95% of all procedures. There was no significant difference in the rate of permanent complications between the two procedures although temporary hypocalcaemia was significantly more common following total thyroidectomy. Permanent hypoparathyroidism resulted in one patient each who underwent total thyroidectomy (0.8%) and subtotal thyroidectomy (0.1%). Permanent recurrent laryngeal nerve palsy occurred in one patient who underwent total thyroidectomy (0.8%) and 5 patients undergoing subtotal thyroidectomy (0.4%).
CONCLUSION: Given that subtotal thyroidectomy provides an unpredictable outcome and that the risk of permanent complications is no greater than with total thyroidectomy, there appears little logical reason to continue to recommend subtotal thyroidectomy for the surgical management of Graves' disease. We believe that Graves' disease should join the increasing list of thyroid conditions for which total thyroidectomy is the preferred option.

Entities:  

Mesh:

Year:  2002        PMID: 12028087     DOI: 10.1046/j.1445-2197.2002.02400.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  24 in total

1.  Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.

Authors:  Annamaria De Bellis; Giovanni Conzo; Gilda Cennamo; Elena Pane; Giuseppe Bellastella; Caterina Colella; Assunta Dello Iacovo; Vanda Amoresano Paglionico; Antonio Agostino Sinisi; Jack R Wall; Antonio Bizzarro; Antonio Bellastella
Journal:  Endocrine       Date:  2011-11-16       Impact factor: 3.633

2.  Alternating from subtotal thyroid resection to total thyroidectomy in the treatment of Graves' disease prevents recurrences but increases the frequency of permanent hypoparathyroidism.

Authors:  Johannes Järhult; Per-Olof Andersson; Linda Duncker
Journal:  Langenbecks Arch Surg       Date:  2011-12-09       Impact factor: 3.445

3.  Disparity in the management of Graves' disease observed at an urban county hospital: a decade-long experience.

Authors:  Judy Jin; Victor Sandoval; Mary E Lawless; Ashwini R Sehgal; Christopher R McHenry
Journal:  Am J Surg       Date:  2012-02-07       Impact factor: 2.565

4.  Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients.

Authors:  A Bergenfelz; S Jansson; A Kristoffersson; H Mårtensson; E Reihnér; G Wallin; I Lausen
Journal:  Langenbecks Arch Surg       Date:  2008-07-17       Impact factor: 3.445

5.  Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.

Authors:  Vishnu Sundaresh; Juan P Brito; Prabin Thapa; Rebecca S Bahn; Marius N Stan
Journal:  Thyroid       Date:  2017-02-06       Impact factor: 6.568

6.  Hypocalcaemia after total thyroidectomy for Graves' disease and for benign atoxic multinodular goitre.

Authors:  Páll Hallgrimsson; E Nordenström; A Bergenfelz; M Almquist
Journal:  Langenbecks Arch Surg       Date:  2012-09-14       Impact factor: 3.445

7.  Risk factors for medically treated hypocalcemia after surgery for Graves' disease: a Swedish multicenter study of 1,157 patients.

Authors:  P Hallgrimsson; E Nordenström; M Almquist; A O J Bergenfelz
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

8.  Safety and efficacy of surgical management of hyperthyroidism: 15-year experience from a tertiary care center in a developing country.

Authors:  P V Pradeep; Amit Agarwal; Mukta Baxi; Gaurav Agarwal; Sushil Kumar Gupta; S K Mishra
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

Review 9.  Short and long-term impact of parathyroid autotransplantation on parathyroid function after total thyroidectomy.

Authors:  Gabrielle Hicks; Robert George; Mark Sywak
Journal:  Gland Surg       Date:  2017-12

10.  Long-term outcome of Graves' disease patients treated in a region with iodine deficiency: relapse rate increases in years with thionamides.

Authors:  Neslihan Basçil Tütüncü; Tanju Tütüncü; Ali Ozgen; Tomris Erbas
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.